ViewsML, the Vancouver-based company developing what it calls the world’s first virtual biomarker library, closed an oversubscribed 4.9millionseedroundearlierthisyear.WittingtonVentures,theTorontoventurearmoftheWestonfamilyholdingcompany,ledtheround.NewinvestorsMayoClinicandContinuumHealthVenturesparticipatedalongsiderepeatbackersincludingDebiopharm.InanThepostMayoClinicbacksViewsMLin4.9 million seed round earlier this year. Wittington Ventures, the Toronto venture arm of the Weston family holding company, led the round. New investors Mayo Clinic and Continuum Health Ventures participated alongside repeat backers including Debiopharm. In an… The post Mayo Clinic backs ViewsML in 4.9M round to advance virtual biomarker staining appeared first on Research & Development World .